124 related articles for article (PubMed ID: 33529484)
1. Deoxyribonuclease I Inhibitory Properties, Molecular Docking and Molecular Dynamics Simulations of 1-(Pyrrolidin-2-yl)propan-2-one Derivatives.
Ilić BS; Gajić M; Bondžić BP; Džambaski Z; Kocić G; Šmelcerović A
Chem Biodivers; 2021 Mar; 18(3):e2000996. PubMed ID: 33529484
[TBL] [Abstract][Full Text] [Related]
2. 1,2,3,4-Tetrahydroisoquinoline Derivatives as a Novel Deoxyribonuclease I Inhibitors.
Gajić M; Ilić BS; Bondžić BP; Džambaski Z; Kojić VV; Jakimov DS; Kocić G; Šmelcerović A
Chem Biodivers; 2021 Aug; 18(8):e2100261. PubMed ID: 34170076
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazoles as novel deoxyribonuclease I inhibitors.
Kolarević A; Ilić BS; Anastassova N; Mavrova AT; Yancheva D; Kocić G; Šmelcerović A
J Cell Biochem; 2018 Nov; 119(11):8937-8948. PubMed ID: 30054936
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and DNase I Inhibitory Properties of New Squaramides.
Ruseva N; Sbirkova-Dimitrova H; Atanasova M; Marković A; Šmelcerović Ž; Šmelcerović A; Bakalova A; Cherneva E
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677597
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and analysis of 4-oxothiazolidines as potential dual inhibitors of deoxyribonuclease I and xanthine oxidase.
Gajić M; Džambaski Z; Ilić BS; Kocić G; Bondžić BP; Šmelcerović A
Chem Biol Interact; 2021 Aug; 345():109536. PubMed ID: 34058176
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones.
Bondžić BP; Džambaski Z; Kolarević A; Đorđević A; Anderluh M; Šmelcerović A
Future Med Chem; 2019 Sep; 11(18):2415-2426. PubMed ID: 31526044
[No Abstract] [Full Text] [Related]
7. Synthesis and DNase I inhibitory properties of some 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines.
Ts Mavrova A; Dimov S; Yancheva D; Kolarević A; Ilić BS; Kocić G; Šmelcerović A
Bioorg Chem; 2018 Oct; 80():693-705. PubMed ID: 30064080
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and DNase I inhibitory properties of some 4-thiazolidinone derivatives.
Kolarević A; Ilić BS; Kocić G; Džambaski Z; Šmelcerović A; Bondžić BP
J Cell Biochem; 2019 Jan; 120(1):264-274. PubMed ID: 30171712
[TBL] [Abstract][Full Text] [Related]
9. 4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition.
Smelcerovic A; Zivkovic A; Ilic BS; Kolarevic A; Hofmann B; Steinhilber D; Stark H
Bioorg Chem; 2020 Jan; 95():103528. PubMed ID: 31918397
[TBL] [Abstract][Full Text] [Related]
10. Chloro-substituted pyridine squaramates as new DNase I inhibitors: Synthesis, structural characterization, in vitro evaluation and molecular docking studies.
Ruseva N; Atanasova M; Sbirkova-Dimitrova H; Marković A; Šmelcerović Ž; Šmelcerović A; Cherneva E; Bakalova A
Chem Biol Interact; 2023 Dec; 386():110772. PubMed ID: 37898285
[TBL] [Abstract][Full Text] [Related]
11. Thiazole derivatives as dual inhibitors of deoxyribonuclease I and 5-lipoxygenase: A promising scaffold for the development of neuroprotective drugs.
Marković A; Živković A; Atanasova M; Doytchinova I; Hofmann B; George S; Kretschmer S; Rödl C; Steinhilber D; Stark H; Šmelcerović A
Chem Biol Interact; 2023 Aug; 381():110542. PubMed ID: 37224992
[TBL] [Abstract][Full Text] [Related]
12. 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.
Zahov S; Garzinsky D; Hanekamp W; Lehr M
Bioorg Med Chem; 2017 Feb; 25(3):825-837. PubMed ID: 27989417
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1.
Mould DP; Bremberg U; Jordan AM; Geitmann M; McGonagle AE; Somervaille TCP; Spencer GJ; Ogilvie DJ
Bioorg Med Chem Lett; 2017 Oct; 27(20):4755-4759. PubMed ID: 28927796
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents.
Jan MS; Ahmad S; Hussain F; Ahmad A; Mahmood F; Rashid U; Abid OU; Ullah F; Ayaz M; Sadiq A
Eur J Med Chem; 2020 Jan; 186():111863. PubMed ID: 31740050
[TBL] [Abstract][Full Text] [Related]
16. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A
Althaus J; Hake T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016; 31(sup1):131-140. PubMed ID: 27162011
[TBL] [Abstract][Full Text] [Related]
17. 1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: bioisosteric replacement of the carboxylic acid and carboxamide moiety.
Hess M; Schulze Elfringhoff A; Lehr M
Bioorg Med Chem; 2007 Apr; 15(8):2883-91. PubMed ID: 17320401
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
Tang J; Liu J; Wu F
Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
[TBL] [Abstract][Full Text] [Related]
19. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
